세계의 건강 특화형 웨어러블 및 의료용 일렉트로닉스 시장 예측(-2032년) - 제품 유형별, 이용 사례별, 유통 채널별, 용도별, 지역별 분석

According to Stratistics MRC, the Global Health-Focused Wearables & Medical Electronics Market is accounted for $20.7 billion in 2025 and is expected to reach $36.7 billion by 2032 growing at a CAGR of 8.5% during the forecast period. Health-focused wearables and medical electronics are specialized devices designed to monitor, diagnose, or support physiological functions through continuous, non-invasive interaction with the human body. These systems integrate sensors, microprocessors, and wireless connectivity to track vital signs, activity levels, and biometric data in real time. Commonly used in chronic disease management, fitness, and remote patient care, they enhance personalized healthcare delivery. Emphasizing accuracy, comfort, and data security, these technologies contribute to preventive medicine, early intervention, and improved clinical outcomes.

According to Nature Electronics, the global market for wearable medical devices surpassed $20 billion in 2021, with cardiac monitoring and glucose tracking accounting for over 60% of clinical-grade wearable deployments.

Market Dynamics:

Driver:

Shift to remote patient monitoring (RPM) and telemedicine

Wearable biosensors and connected medical electronics now enable continuous tracking of vital signs, empowering clinicians to intervene early and personalize treatment plans. Integration with cloud-based platforms and AI-driven analytics is enhancing diagnostic accuracy and reducing hospital readmission rates. As healthcare systems pivot toward decentralized care, demand for interoperable, patient-centric devices is accelerating. This shift is also supported by reimbursement reforms and digital infrastructure upgrades across key markets.

Restraint:

Limited battery life

Continuous data transmission, real-time monitoring, and advanced sensor functionalities place high energy demands on compact form factors. Frequent recharging disrupts usability, particularly for elderly or mobility-impaired users. Moreover, manufacturers are exploring low-power chipsets and energy harvesting technologies, but scalability and cost-efficiency remain hurdles. Until battery longevity improves significantly, device adoption may be constrained in high-dependency clinical settings.

Opportunity:

Expansion into clinical-grade devices

Devices capable of FDA or CE certification are gaining traction in hospital-at-home programs, post-operative care, and chronic disease monitoring. Innovations in biosignal fidelity, multi-parameter sensing, and secure data transmission are enabling wearables to meet stringent clinical validation standards. Startups and incumbents alike are investing in hybrid platforms that combine lifestyle tracking with diagnostic-grade performance. This evolution is expected to unlock new reimbursement pathways and broaden the scope of remote diagnostics.

Threat:

Consumer apathy and low retention rates

Many users abandon devices due to lack of perceived value, poor user interface design, or data fatigue. Without meaningful feedback loops or integration into care pathways, wearables risk becoming novelty items. Additionally, privacy concerns and limited interoperability with electronic health records (EHRs) deter sustained use. Brands must prioritize behavioral science-driven design and personalized insights to improve retention. Failure to address these issues could lead to stagnation in consumer-grade segments.

Covid-19 Impact:

The pandemic catalyzed a surge in demand for remote diagnostics and health monitoring solutions, driving rapid innovation in wearable medical electronics. Lockdowns and overwhelmed healthcare systems prompted patients to seek alternatives to in-person consultations, boosting telemedicine and RPM adoption. Wearables equipped with pulse oximeters, ECG sensors, and temperature monitors became essential tools for early symptom detection and post-COVID recovery tracking. However, supply chain disruptions and semiconductor shortages temporarily hindered production and distribution.

The diagnostic & monitoring devices segment is expected to be the largest during the forecast period

The diagnostic & monitoring devices segment is expected to account for the largest market share during the forecast period due to its critical role in chronic disease management and preventive care. Devices such as smart patches, wearable ECG monitors, and connected blood pressure cuffs are increasingly used in clinical workflows and home settings. Their ability to deliver real-time data to healthcare providers enhances treatment precision and reduces emergency interventions. The proliferation of AI-enabled diagnostics and cloud-based platforms further strengthens the segment's relevance.

The consumer-grade devices segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the consumer-grade devices segment is predicted to witness the highest growth rate driven by rising health consciousness and lifestyle tracking trends. Products like fitness bands, smartwatches with health sensors, and sleep monitors are gaining popularity among younger demographics and wellness-focused users. Integration with mobile apps and gamified health platforms is boosting user engagement. Moreover, the blurring lines between wellness and clinical utility are prompting manufacturers to enhance sensor accuracy and data reliability.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share propelled by its advanced healthcare infrastructure and high adoption of digital health technologies. The region benefits from strong reimbursement frameworks, active regulatory support, and a thriving ecosystem of medtech innovators. Strategic partnerships between tech giants and healthcare providers are accelerating product development and deployment. Additionally, rising prevalence of chronic conditions and aging populations are fueling demand for continuous monitoring solutions.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by expanding healthcare access, rising disposable incomes, and growing awareness of preventive health. Countries like China, India, and South Korea are witnessing rapid adoption of wearables for both wellness and clinical applications. Government-led initiatives promoting digital health and local manufacturing are further stimulating market growth. The region's large population base and increasing smartphone penetration create fertile ground for scalable RPM solutions.

Key players in the market

Some of the key players in Health-Focused Wearables & Medical Electronics Market include Meta Platforms, Inc., Apple Inc., Sony Corporation, HTC Corporation, Lenovo Group Ltd., Microsoft Corporation, Google LLC, Samsung Electronics Co., Ltd., XREAL, Viture, Pico Interactive, Magic Leap, Inc., Vuzix Corporation, Varjo Technologies, RealWear, Inc., Rokid, Epson America, Inc., Goertek, HP Inc. and RayNeo.

Key Developments:

In August 2025, HTC unveiled the VIVE Eagle AI glasses, a consumer-focused AI eyewear product with bundled AI services. The release positions VIVE Eagle as HTC's move into lightweight AI eyewear and consumer AR experiences.

In June 2025, Apple announced expanded Apple Intelligence features, developer tools, and a new universal "liquid glass" software design. Apple positioned these updates as enabling private, on-device AI and richer UX across iPhone, iPad, Mac and Vision Pro.

In June 2025, XREAL announced collaborations and distributor agreements at CES 2025 and rolled product updates (One Pro availability) through mid-2025. The company highlighted expanding global availability and modular camera/feature upgrades for its AR glasses.

Product Types Covered:

• Diagnostic & Monitoring Devices
• Therapeutic Devices
• Wearable Form Factors
• Other Product Types

Use Cases Covered:

• Consumer-Grade Devices
• Clinical-Grade Devices

Distribution Channels Covered:

• Online Channels
• Hypermarkets
• Pharmacies
• Other Distribution Channels

Applications Covered:

• General Health & Fitness
• Remote Patient Monitoring (RPM)
• Home Healthcare
• Sports & Fitness
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Health-Focused Wearables & Medical Electronics Market, By Product Type

• 5.1 Introduction
• 5.2 Diagnostic & Monitoring Devices
  • 5.2.1 Vital Sign Monitoring Devices
  • 5.2.2 Neuromonitoring Devices
  • 5.2.3 Sleep Monitoring Devices
  • 5.2.4 Glucose Monitoring Devices
  • 5.2.5 Fetal & Obstetric Monitors
  • 5.2.6 Other Product Types
• 5.3 Therapeutic Devices
  • 5.3.1 Pain Management Devices
  • 5.3.2 Rehabilitation Devices
  • 5.3.3 Insulin/Glucose Pumps
  • 5.3.4 Respiratory Therapy Devices
• 5.4 Wearable Form Factors
  • 5.4.1 Smartwatches
  • 5.4.2 Fitness Trackers/Bands
  • 5.4.3 Hearables
  • 5.4.4 Smart Clothing/Garments
  • 5.4.5 Patches
• 5.5 Other Product Types

6 Global Health-Focused Wearables & Medical Electronics Market, By Use Case

• 6.1 Introduction
• 6.2 Consumer-Grade Devices
• 6.3 Clinical-Grade Devices

7 Global Health-Focused Wearables & Medical Electronics Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Online Channels
• 7.3 Hypermarkets
• 7.4 Pharmacies
• 7.5 Other Distribution Channels

8 Global Health-Focused Wearables & Medical Electronics Market, By Application

• 8.1 Introduction
• 8.2 General Health & Fitness
• 8.3 Remote Patient Monitoring (RPM)
• 8.4 Home Healthcare
• 8.5 Sports & Fitness
• 8.6 Other Applications

9 Global Health-Focused Wearables & Medical Electronics Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Apple Inc.
• 11.2 Fitbit
• 11.3 Garmin Ltd.
• 11.4 Samsung Electronics Co., Ltd.
• 11.5 Huawei Technologies Co., Ltd.
• 11.6 Masimo Corporation
• 11.7 Dexcom Inc.
• 11.8 Abbott Laboratories
• 11.9 Medtronic plc
• 11.10 BioTelemetry Inc
• 11.11 Koninklijke Philips N.V.
• 11.12 Omron Healthcare Inc.
• 11.13 Withings
• 11.14 iRhythm Technologies Inc.
• 11.15 AliveCor Inc.
• 11.16 NeuroMetrix Inc.
• 11.17 Sensoria Inc.
• 11.18 Preventice Solutions
• 11.19 Biobeat Technologies Ltd.
• 11.20 Vivalink Inc